OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Highly Potent, Selective, and Competitive Indole-Based MAO-B Inhibitors Protect PC12 Cells against 6-Hydroxydopamine- and Rotenone-Induced Oxidative Stress
Mohamed H. Elsherbeny, Jushin Kim, Noha Gouda, et al.
Antioxidants (2021) Vol. 10, Iss. 10, pp. 1641-1641
Open Access | Times Cited: 22
Mohamed H. Elsherbeny, Jushin Kim, Noha Gouda, et al.
Antioxidants (2021) Vol. 10, Iss. 10, pp. 1641-1641
Open Access | Times Cited: 22
Showing 22 citing articles:
Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update
Noha Gouda, Ahmed Elkamhawy, Jungsook Cho
Biomedicines (2022) Vol. 10, Iss. 2, pp. 371-371
Open Access | Times Cited: 57
Noha Gouda, Ahmed Elkamhawy, Jungsook Cho
Biomedicines (2022) Vol. 10, Iss. 2, pp. 371-371
Open Access | Times Cited: 57
Dual Inhibitors of Brain Carbonic Anhydrases and Monoamine Oxidase-B Efficiently Protect against Amyloid-β-Induced Neuronal Toxicity, Oxidative Stress, and Mitochondrial Dysfunction
Simone Giovannuzzi, Daniel Chavarria, Gustavo Provensi, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 4170-4193
Closed Access | Times Cited: 9
Simone Giovannuzzi, Daniel Chavarria, Gustavo Provensi, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 4170-4193
Closed Access | Times Cited: 9
Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's disease: synthesis, pharmacology, toxicity and docking studies
Muhammad Aamir Javed, Saba Bibi, Muhammad Saeed Jan, et al.
RSC Advances (2022) Vol. 12, Iss. 35, pp. 22503-22517
Open Access | Times Cited: 27
Muhammad Aamir Javed, Saba Bibi, Muhammad Saeed Jan, et al.
RSC Advances (2022) Vol. 12, Iss. 35, pp. 22503-22517
Open Access | Times Cited: 27
Pelargonium graveolens Attenuates Rotenone-Induced Parkinson’s Disease in a Rat Model: Role of MAO-B Inhibition and In Silico Study
Rana M. Merghany, Salma A. El-Sawi, Asmaa F. Aboul Naser, et al.
Molecular Neurobiology (2025)
Open Access
Rana M. Merghany, Salma A. El-Sawi, Asmaa F. Aboul Naser, et al.
Molecular Neurobiology (2025)
Open Access
Network-Based Drug Optimization toward the Treatment of Parkinson’s Disease: NRF2, MAO-B, Oxidative Stress, and Chronic Neuroinflammation
Pablo Duarte, Francisco J. Sanchez-Porro, Enrique Crisman, et al.
Journal of Medicinal Chemistry (2025) Vol. 68, Iss. 3, pp. 3495-3517
Closed Access
Pablo Duarte, Francisco J. Sanchez-Porro, Enrique Crisman, et al.
Journal of Medicinal Chemistry (2025) Vol. 68, Iss. 3, pp. 3495-3517
Closed Access
Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screening
Ahmed Elkamhawy, Usama M. Ammar, Minkyoung Kim, et al.
Archives of Pharmacal Research (2025)
Open Access
Ahmed Elkamhawy, Usama M. Ammar, Minkyoung Kim, et al.
Archives of Pharmacal Research (2025)
Open Access
Elucidating the antioxidant potential of some flavanones as MAO-B inhibitors through DAM, in silico molecular docking and computational analysis
E. Athira, S. Akhila Darsan, Stephen C. Davis, et al.
Plant Molecular Biology (2025) Vol. 115, Iss. 2
Closed Access
E. Athira, S. Akhila Darsan, Stephen C. Davis, et al.
Plant Molecular Biology (2025) Vol. 115, Iss. 2
Closed Access
Overexpression of Neuroglobin Promotes Energy Metabolism and Autophagy Induction in Human Neuroblastoma SH-SY5Y Cells
Valeria Manganelli, Illari Salvatori, Michele Costanzo, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3394-3394
Open Access | Times Cited: 24
Valeria Manganelli, Illari Salvatori, Michele Costanzo, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3394-3394
Open Access | Times Cited: 24
Inhibition of monoamine oxidase-a increases respiration in isolated mouse cortical mitochondria
Olivia J. Kalimon, Hemendra J. Vekaria, Greg A. Gerhardt, et al.
Experimental Neurology (2023) Vol. 363, pp. 114356-114356
Open Access | Times Cited: 9
Olivia J. Kalimon, Hemendra J. Vekaria, Greg A. Gerhardt, et al.
Experimental Neurology (2023) Vol. 363, pp. 114356-114356
Open Access | Times Cited: 9
Design, Synthesis, Biological Evaluation, and Molecular Dynamics Studies of Novel Lapatinib Derivatives
Ahmed Elkamhawy, Seohyun Son, Hwa Young Lee, et al.
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 43-43
Open Access | Times Cited: 15
Ahmed Elkamhawy, Seohyun Son, Hwa Young Lee, et al.
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 43-43
Open Access | Times Cited: 15
Novel Hybrid Indole-Based Caffeic Acid Amide Derivatives as Potent Free Radical Scavenging Agents: Rational Design, Synthesis, Spectroscopic Characterization, In Silico and In Vitro Investigations
Ahmed Elkamhawy, Na Kyoung Oh, Noha Gouda, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 141-141
Open Access | Times Cited: 8
Ahmed Elkamhawy, Na Kyoung Oh, Noha Gouda, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 141-141
Open Access | Times Cited: 8
Challenges and Discoveries in Polypharmacology of Neurodegenerative Diseases
Luciana Scotti, Teresa Carolliny Moreira Lustoza Rodrigues, Natália Ferreira de Sousa, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 5, pp. 349-370
Closed Access | Times Cited: 8
Luciana Scotti, Teresa Carolliny Moreira Lustoza Rodrigues, Natália Ferreira de Sousa, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 5, pp. 349-370
Closed Access | Times Cited: 8
Novel coumarin benzamides as potent and reversible monoamine oxidase-B inhibitors: Design, synthesis, and neuroprotective effects
Ashraf K. El‐Damasy, Jong‐Min Oh, Hyun Ji Kim, et al.
Bioorganic Chemistry (2023) Vol. 142, pp. 106939-106939
Closed Access | Times Cited: 6
Ashraf K. El‐Damasy, Jong‐Min Oh, Hyun Ji Kim, et al.
Bioorganic Chemistry (2023) Vol. 142, pp. 106939-106939
Closed Access | Times Cited: 6
Omarigliptin Mitigates 6-Hydroxydopamine- or Rotenone-Induced Oxidative Toxicity in PC12 Cells by Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Actions
Noha Gouda, Jungsook Cho
Antioxidants (2022) Vol. 11, Iss. 10, pp. 1940-1940
Open Access | Times Cited: 10
Noha Gouda, Jungsook Cho
Antioxidants (2022) Vol. 11, Iss. 10, pp. 1940-1940
Open Access | Times Cited: 10
Chemical space navigation by machine learning models for discovering selective MAO-B enzyme inhibitors for Parkinson’s disease
P. Catherene Tomy, C. Gopi Mohan
Artificial Intelligence Chemistry (2023) Vol. 1, Iss. 2, pp. 100012-100012
Open Access | Times Cited: 5
P. Catherene Tomy, C. Gopi Mohan
Artificial Intelligence Chemistry (2023) Vol. 1, Iss. 2, pp. 100012-100012
Open Access | Times Cited: 5
Lipid Carrier Nanostructured Astilbin Ameliorates Rotenone-Induced Neurodegeneration in Mice Brain via Modulation of GSK3β-Nrf2 Signaling Pathways
Wenyuan Xu, You Dai
Journal of Oleo Science (2024) Vol. 73, Iss. 3, pp. 371-387
Open Access | Times Cited: 1
Wenyuan Xu, You Dai
Journal of Oleo Science (2024) Vol. 73, Iss. 3, pp. 371-387
Open Access | Times Cited: 1
Rational design, synthesis, biological evaluation, and molecular modeling of novel naphthamide derivatives possessing potent, reversible, and competitive inhibitory mode of action over human monoamine oxidase
Ahmed Elkamhawy, Jong‐Min Oh, Minkyoung Kim, et al.
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 179-193
Closed Access | Times Cited: 1
Ahmed Elkamhawy, Jong‐Min Oh, Minkyoung Kim, et al.
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 179-193
Closed Access | Times Cited: 1
Chalcone‐based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studies
Hwa Young Lee, Ahmed Elkamhawy, Ahmed A. Al‐Karmalawy, et al.
Archiv der Pharmazie (2024)
Open Access | Times Cited: 1
Hwa Young Lee, Ahmed Elkamhawy, Ahmed A. Al‐Karmalawy, et al.
Archiv der Pharmazie (2024)
Open Access | Times Cited: 1
Novel cudraisoflavone J derivatives as potent neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/HO-1 signaling
Qili Lu, Noha Gouda, Guofeng Quan, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114692-114692
Closed Access | Times Cited: 6
Qili Lu, Noha Gouda, Guofeng Quan, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114692-114692
Closed Access | Times Cited: 6
In vitro/in vivo effects of some new 2,5-disubstituted 1,3,4-oxadiazole and hydrazone analogues targeting Parkinson's disease
Valentin Karabelyov, Violina T. Angelova, Martin Sharkov, et al.
Journal of Molecular Structure (2023) Vol. 1288, pp. 135755-135755
Closed Access | Times Cited: 3
Valentin Karabelyov, Violina T. Angelova, Martin Sharkov, et al.
Journal of Molecular Structure (2023) Vol. 1288, pp. 135755-135755
Closed Access | Times Cited: 3
Prominent Neuroprotective Potential of Indole-2-N-methylpropargylamine: High Affinity and Irreversible Inhibition Efficiency towards Monoamine Oxidase B Revealed by Computational Scaffold Analysis
Lucija Vrban, Robert Vianello
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1292-1292
Open Access
Lucija Vrban, Robert Vianello
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1292-1292
Open Access
Development of novel aza-stilbenes as a new class of selective MAO-B inhibitors for the treatment of Parkinson’s disease
Damijan Knez, Fen Wang, Wen-Xiang Duan, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107877-107877
Open Access
Damijan Knez, Fen Wang, Wen-Xiang Duan, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107877-107877
Open Access
